Mission Bio Inc.
400 E Jamie Ct.
South San Francisco
Tel: (415) 854-0058
About Mission Bio Inc.
Mission Bio is a life sciences company that accelerates discoveries and cures for a wide range of diseases by equipping researchers with the tools they need to better measure and predict our resistance and response to new therapies. Mission Bio's multi-omics approach improves time-to-market for new therapeutics, including innovative cell and gene therapies that provide new pathways to health. Founded in 2014, Mission Bio has secured investment from Novo Growth, Cota Capital, Agilent Technologies, Mayfield Fund, and others.
The company's Tapestri platform gives researchers around the globe the power to interrogate every molecule in a cell together, providing a comprehensive understanding of activity from a single sample. Tapestri is the only commercialized multi-omics platform capable of analyzing DNA and protein simultaneously from the same sample at single-cell resolution. The Tapestri Platform is being utilized by customers at leading research centers, pharmaceutical, and diagnostics companies worldwide to develop treatments and eventually cures for cancer.
Visit missionbio.com to learn more.
Characterize your cell and gene therapies better with Tapestri CGT Solutions. Develop safe and efficacious therapies with single-cell analysis. Measure genomic alterations from virus and CRISPR, along with immunophenotype.
All with single-cell resolution.
No cell culture required.
Shorten your workflow from weeks to days.
Partner with our skilled scientific team to develop your assay.
Gain confidence in your therapies so they can reach patients faster.
48 articles about Mission Bio Inc.
8/22/2019Today, Mission Bio announced the addition of Copy Number Analysis, which extends the platform’s Copy Number Variation capabilities without any change to the current workflow.
4/26/2019Companies strengthen leadership teams with C-suite and boards of directors appointments, with new hires at Sandoz, Mission Bio, SkinBio, Epic Sciences, and more.
South San Francisco-based Mission Bio, the only company providing single-cell DNA sequencing, entered into a collaboration with LabCorp, to harness the abilities of the company’s Tapestri Platform to provide more precise clinical trials.
The San Francisco Business Times recently looked at top alumni from Bay Area incubators. Some of those companies are now brand-name companies like Uber and Reddit. Here’s a look at the biotech companies on their list.
Creators of the world’s leading platform for Precision Genomics chosen as one of the most promising and innovative companies
Mission Bio today announced the launch of Tapestri Custom Panels, an industry-first single-cell DNA capability that allows researchers and clinicians to focus on the genetic mutations most impactful to their research and patients.
Mission Bio, Inc., a pioneer in single-cell DNA analysis, today announced it has secured $10 million in Series A funding. Silicon Valley venture capital firm Mayfield Fund led the round.